Evidence map›Paper›PMID 15923639›Full record

ArticleMolecular and cellular biology2005

Rab3D regulates a novel vesicular trafficking pathway that is required for osteoclastic bone resorption.

Nathan J Pavlos, Jiake Xu, Dietmar Riedel, Joyce S G Yeoh, Steven L Teitelbaum, John M Papadimitriou, Reinhard Jahn, F Patrick Ross, Ming H Zheng

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
2.3field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 98 citations in OpenAlex.

  1. Article
  2. Article
  3. Role of endosomal RANKL-LGR4 signaling during osteoclast differentiation.Journal of molecular medicine (Berlin, Germany) · 2025
    Article
  4. Article
  5. Article
  6. Lysosomal biogenesis and function in osteoclasts: a comprehensive review.Frontiers in cell and developmental biology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Genetic Determinants of Paget's Disease of Bone.Current osteoporosis reports · 2021
    Review
  12. Article
  13. A cancer in hybrids.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  14. Oncogenic allelic interaction inProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  15. Rab GTPases in Osteoclastic Bone Resorption and Autophagy.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Nathan J PavlosUnit of Orthopaedics, School of Surgery and Pathology, University of Western Australia, 2nd Floor M Block, QEII Medical Centre, Nedlands, Perth, Western Australia 6009, Australia.
Jiake Xu
Dietmar Riedel
Joyce S G Yeoh
Steven L Teitelbaum
John M Papadimitriou
Reinhard Jahn
F Patrick Ross
Ming H Zheng
Max Planck Institute for Biophysical Chemistry · DEWashington University in St. Louis · USQueen Elizabeth II Medical Centre · AU

Funding

Mechanisms of RANKL Mediated Osteoclast ActivationR01AR032788 · NIAMS · WASHINGTON UNIVERSITY · PI TEITELBAUM, STEVEN L · 1987 to 2012
$6.6M
MECHANISMS OF AVB3 INTEGRIN MEDIATED BONE RESORPTIONR01AR046523 · NIAMS · WASHINGTON UNIVERSITY · PI TEITELBAUM, STEVEN L · 2000 to 2009
$4.0M
Mechanisms of AVB3 Integrin Mediated Bone ResorptionR37AR046523 · NIAMS · WASHINGTON UNIVERSITY · PI TEITELBAUM, STEVEN L · 2010 to 2019
$3.3M
M-CSF SIGNALING IN OSTEOCLAST FORMATION AND FUNCTIONR01AR046852 · NIAMS · WASHINGTON UNIVERSITY · PI ROSS, F. PATRICK · 2000 to 2008
$2.2M
RANK Ligand is a Bone Anabolic AgentR01AR048853 · NIAMS · WASHINGTON UNIVERSITY · PI TEITELBAUM, STEVEN L · 2002 to 2006
$1.8M
Bone Loss and Its Prevention in HIV PatientsR01AR048812 · NIAMS · WASHINGTON UNIVERSITY · PI ROSS, F. PATRICK · 2002 to 2006
$1.7M
NIAMS NIH HHS AR32788NIAMS NIH HHS AR46523NIAMS NIH HHS AR46852NIAMS NIH HHS AR48812NIAMS NIH HHS AR48853NIAMS NIH HHS R01 AR032788NIAMS NIH HHS R01 AR046523NIAMS NIH HHS R01 AR046852NIAMS NIH HHS R01 AR048812NIAMS NIH HHS R01 AR048853NIAMS NIH HHS R37 AR046523
6 · The paper itself

Abstract

Rab3 proteins are a subfamily of GTPases, known to mediate membrane transport in eukaryotic cells and play a role in exocytosis. Our data indicate that Rab3D is the major Rab3 species expressed in osteoclasts. To investigate the role of Rab3D in osteoclast physiology we examined the skeletal architecture of Rab3D-deficient mice and found an osteosclerotic phenotype. Although basal osteoclast number in null animals is normal the total eroded surface is significantly reduced, suggesting that the resorptive defect is due to attenuated osteoclast activity. Consistent with this hypothesis, ultrastructural analysis reveals that Rab3D(-/-) osteoclasts exhibit irregular ruffled borders. Furthermore, while overexpression of wild-type, constitutively active, or prenylation-deficient Rab3D has no significant effects, overexpression of GTP-binding-deficient Rab3D impairs bone resorption in vitro. Finally, subcellular localization studies reveal that, unlike wild-type or constitutively active Rab3D, which associate with a nonendosomal/lysosomal subset of post-trans-Golgi network (TGN) vesicles, inactive Rab3D localizes to the TGN and inhibits biogenesis of Rab3D-bearing vesicles. Collectively, our data suggest that Rab3D modulates a post-TGN trafficking step that is required for osteoclastic bone resorption.

Indexed as

Bone ResorptionAnimalsBiological TransportCarrier ProteinsCell MembraneCells, CulturedMembrane GlycoproteinsMiceMice, KnockoutMicroscopy, ElectronOrganellesOsteoclastsOsteopetrosisPhenotypeProtein Isoformsrab3 GTP-Binding ProteinsCarrier ProteinsMembrane GlycoproteinsProtein IsoformsRab3d protein, mouserab3 GTP-Binding ProteinsRANK LigandReceptor Activator of Nuclear Factor-kappa BRecombinant Fusion ProteinsTnfrsf11a protein, mouseTnfsf11 protein, mouse

Identifiers

PMID15923639
PMCPMC1140603
OpenAlexW2034597054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.